Literature DB >> 30462170

Evolution of Programmatic Definitions Used in Tuberculosis Prevention and Care.

G B Migliori.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30462170     DOI: 10.1093/cid/ciy990

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  7 in total

1.  Clinical standards for drug-susceptible pulmonary TB.

Authors:  O W Akkerman; R Duarte; S Tiberi; H S Schaaf; C Lange; J W C Alffenaar; J Denholm; A C C Carvalho; M S Bolhuis; S Borisov; J Bruchfeld; A M Cabibbe; J A Caminero; I Carvalho; J Chakaya; R Centis; M P Dalcomo; L D Ambrosio; M Dedicoat; K Dheda; K E Dooley; J Furin; J-M García-García; N A H van Hest; B C de Jong; X Kurhasani; A G Märtson; S Mpagama; M Munoz Torrico; E Nunes; C W M Ong; D J Palmero; R Ruslami; A M I Saktiawati; C Semuto; D R Silva; R Singla; I Solovic; S Srivastava; J E M de Steenwinkel; A Story; M G G Sturkenboom; M Tadolini; Z F Udwadia; A R Verhage; J P Zellweger; G B Migliori
Journal:  Int J Tuberc Lung Dis       Date:  2022-07-01       Impact factor: 3.427

2.  Clinical standards for the assessment, management and rehabilitation of post-TB lung disease.

Authors:  G B Migliori; F M Marx; N Ambrosino; E Zampogna; H S Schaaf; M M van der Zalm; B Allwood; A L Byrne; K Mortimer; R S Wallis; G J Fox; C C Leung; J M Chakaya; B Seaworth; A Rachow; B J Marais; J Furin; O W Akkerman; F Al Yaquobi; A F S Amaral; S Borisov; J A Caminero; A C C Carvalho; D Chesov; L R Codecasa; R C Teixeira; M P Dalcolmo; S Datta; A-T Dinh-Xuan; R Duarte; C A Evans; J-M García-García; G Günther; G Hoddinott; S Huddart; O Ivanova; R Laniado-Laborín; S Manga; K Manika; A Mariandyshev; F C Q Mello; S G Mpagama; M Muñoz-Torrico; P Nahid; C W M Ong; D J Palmero; A Piubello; E Pontali; D R Silva; R Singla; A Spanevello; S Tiberi; Z F Udwadia; M Vitacca; R Centis; L D Ambrosio; G Sotgiu; C Lange; D Visca
Journal:  Int J Tuberc Lung Dis       Date:  2021-10-01       Impact factor: 3.427

Review 3.  Treatment of Drug-Resistant Tuberculosis.

Authors:  Sundari R Mase; Terence Chorba
Journal:  Clin Chest Med       Date:  2019-12       Impact factor: 2.878

4.  The absence of evidence of cure is not a risk for recurrent TB among patients treated for TB.

Authors:  L Mantshonyane; B Kgwaadira; R Gross
Journal:  Int J Tuberc Lung Dis       Date:  2021-06-01       Impact factor: 3.427

5.  Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis.

Authors:  Jonathon R Campbell; Dennis Falzon; Fuad Mirzayev; Ernesto Jaramillo; Giovanni Battista Migliori; Carole D Mitnick; Norbert Ndjeka; Dick Menzies
Journal:  Emerg Infect Dis       Date:  2020-03-17       Impact factor: 6.883

Review 6.  The definition of tuberculosis infection based on the spectrum of tuberculosis disease.

Authors:  Giovanni Battista Migliori; Catherine W M Ong; Linda Petrone; Lia D'Ambrosio; Rosella Centis; Delia Goletti
Journal:  Breathe (Sheff)       Date:  2021-09

7.  Updated WHO definitions for tuberculosis outcomes: Simplified, unified and future-proofed.

Authors:  J A M Stadler
Journal:  Afr J Thorac Crit Care Med       Date:  2022-07-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.